"The initiation of this fasedienol repeat dose study marks another significant milestone in our U.S. Phase 3 program for the acute treatment of social anxiety disorder," said Shawn Singh ...

"The initiation of this fasedienol repeat dose study marks another significant milestone in our U.S. Phase 3 program for the acute treatment of social anxiety disorder,” said Shawn Singh ...

Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced enrollment of the first subject in a repeat dose ...

HCL Technologies Ltd (HCL Tech) Q3 results came more or less in line with expectations. Even as the IT major narrowed its revenue guidance, analysts said the hurdle rate for HCL Tech to now re ...

Background High dose oral thiamine may have a role in treating ... was to determine the pharmacokinetic profile of oral thiamine hydrochloride at 100 mg, 500 mg and 1500 mg doses in healthy ...

Journaling, grounding techniques, moving more, and meditation are some of the techniques that can help you reduce and manage anxiety symptoms. Stress is the body’s natural response to a real or ...

Dec. 17, 2024 — Almost three quarters of adolescents in Australia experience clinically significant depression or anxiety symptoms, with most being chronic, according to a new study. And ...

Wegovy (semaglutide) is a prescription drug used for weight management and heart disease related to obesity. Wegovy can cause side effects that range from mild to serious. Examples include ...

BMC Clin Pharmacol. 2012;12(4):1-10. Figures 3 and 4 show semi-log plots of the terminal phase of thiamine concentration vs time plots for each thiamine dose for whole blood and plasma.

For research papers The BMJ has fully open peer review. This means that accepted research papers published from early 2015 onwards usually have their prepublication history posted alongside them on ...

1 Considerable anxiety about the climate crisis is rational, particularly for young people, for whom even 2100 is a tangible date. Deep concern for future human and ecological wellbeing is justified ...

HCL Technologies (HCL Tech) on Monday, January 13, 2025, declared an interim dividend of ₹12 per share and a special dividend of ₹6 per share. The announcement came along with the IT major declaring ...